Brian Collins

Brian Collins is currently serving as the Chief Financial Officer at ViroCell Biologics, a Contract Development and Manufacturing Organization (CDMO) specializing in viral vectors and gene-modified cells for cell and gene therapies. Prior to this role, Brian held the position of Chief Financial Officer at the Cell and Gene Therapy Catapult and Coveris Group, where he played crucial roles in financial management and strategic decision-making. With a strong background in finance and executive roles in various industries, Brian has demonstrated expertise in driving financial growth and operational excellence throughout his career.